• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过双重方法探索 PCSK9 基因对脂蛋白(a)的影响:关联和孟德尔随机化。

Exploring PCSK9 Genetic Impact on Lipoprotein(a) via Dual Approaches: Association and Mendelian Randomization.

机构信息

Department of Dermatology, Chang Gung Memorial Hospital, College of Medicine, Chang Gung University, Tao-Yuan 33305, Taiwan.

Cardiovascular Division, Chang Gung Memorial Hospital, College of Medicine, Chang Gung University, Tao-Yuan 33305, Taiwan.

出版信息

Int J Mol Sci. 2023 Sep 28;24(19):14668. doi: 10.3390/ijms241914668.

DOI:10.3390/ijms241914668
PMID:37834124
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10572552/
Abstract

Previous investigations have suggested an association between the common polymorphism E670G and Lipoprotein(a) (Lp(a)) levels, as well as a link between plasma PCSK9 levels and Lp(a) concentrations. However, the causal relationship between plasma PCSK9 and Lp(a) levels remains uncertain. In this study, we explored the association between E670G polymorphism and Lp(a) levels in 614 healthy Taiwanese individuals. Employing a two-sample Mendelian randomization (MR) analysis using openly accessible PCSK9 and Lp(a) summary statistics from the genome-wide association studies (GWAS) and UK Biobank, we aimed to determine if a causal link exists between plasma PCSK9 levels and Lp(a) concentrations. Our findings reveal that the E670G G allele is independently associated with a decreased likelihood of developing elevated Lp(a) levels. This association persists even after adjusting for common cardiovascular risk factors and irrespective of lipid profile variations. The MR analysis, utilizing six GWAS-associated variants as instrumental variables to predict plasma PCSK9 levels, provides compelling evidence of a causal relationship between plasma PCSK9 levels and Lp(a) concentration. In conclusion, our study not only replicates the association between the E670G polymorphism and Lp(a) levels but also confirms a causative relationship between PCSK9 levels and Lp(a) concentrations through MR analysis.

摘要

先前的研究表明,常见的 E670G 多态性与脂蛋白(a)(Lp(a))水平之间存在关联,以及血浆 PCSK9 水平与 Lp(a)浓度之间存在关联。然而,血浆 PCSK9 与 Lp(a)水平之间的因果关系仍不确定。在这项研究中,我们在 614 名健康的台湾个体中探讨了 E670G 多态性与 Lp(a)水平之间的关联。我们使用来自全基因组关联研究(GWAS)和英国生物库的公开可访问的 PCSK9 和 Lp(a)汇总统计数据,采用两样本 Mendelian 随机化(MR)分析,旨在确定血浆 PCSK9 水平与 Lp(a)浓度之间是否存在因果关系。我们的研究结果表明,E670G G 等位基因与升高的 Lp(a)水平的发生几率降低独立相关。即使在调整了常见的心血管风险因素后,并且无论脂质谱的变化如何,这种关联仍然存在。利用六个与 GWAS 相关的变异作为工具变量来预测血浆 PCSK9 水平的 MR 分析提供了有力的证据,表明血浆 PCSK9 水平与 Lp(a)浓度之间存在因果关系。总之,我们的研究不仅复制了 E670G 多态性与 Lp(a)水平之间的关联,而且通过 MR 分析证实了 PCSK9 水平与 Lp(a)浓度之间的因果关系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3058/10572552/75520b6a75b0/ijms-24-14668-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3058/10572552/980ccb64e897/ijms-24-14668-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3058/10572552/75520b6a75b0/ijms-24-14668-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3058/10572552/980ccb64e897/ijms-24-14668-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3058/10572552/75520b6a75b0/ijms-24-14668-g002.jpg

相似文献

1
Exploring PCSK9 Genetic Impact on Lipoprotein(a) via Dual Approaches: Association and Mendelian Randomization.通过双重方法探索 PCSK9 基因对脂蛋白(a)的影响:关联和孟德尔随机化。
Int J Mol Sci. 2023 Sep 28;24(19):14668. doi: 10.3390/ijms241914668.
2
Common and Rare Variants Associated with Low-Density Lipoprotein Cholesterol Levels and the Risk of Diabetes Mellitus: A Mendelian Randomization Study.常见和罕见变异与低密度脂蛋白胆固醇水平及糖尿病风险的关联:一项孟德尔随机化研究。
Int J Mol Sci. 2022 Sep 8;23(18):10418. doi: 10.3390/ijms231810418.
3
Association between genetically proxied PCSK9 inhibition and prostate cancer risk: A Mendelian randomisation study.基于遗传邻近性的 PCSK9 抑制与前列腺癌风险的关联:一项孟德尔随机化研究。
PLoS Med. 2023 Jan 3;20(1):e1003988. doi: 10.1371/journal.pmed.1003988. eCollection 2023 Jan.
4
Causal associations between insulin and Lp(a) levels in Caucasian population: a Mendelian randomization study.高加索人群中胰岛素与 Lp(a)水平之间的因果关系:一项孟德尔随机化研究。
Cardiovasc Diabetol. 2024 Aug 29;23(1):316. doi: 10.1186/s12933-024-02389-7.
5
Genetic Regulation of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Plasma Levels and Its Impact on Atherosclerotic Vascular Disease Phenotypes.PCSK9(脯氨酰羧肽酶/枯草杆菌蛋白酶 Kexin 9 型)的基因调控及其对动脉粥样硬化血管疾病表型的影响。
Circ Genom Precis Med. 2018 May;11(5):e001992. doi: 10.1161/CIRCGEN.117.001992.
6
Association between lipoprotein (a) and proprotein convertase substilisin/kexin type 9 in patients with heterozygous familial hypercholesterolemia: A case-control study.载脂蛋白(a)与杂合子家族性高胆固醇血症患者前蛋白转化酶枯草溶菌素 9 之间的关系:一项病例对照研究。
Metabolism. 2018 Feb;79:33-41. doi: 10.1016/j.metabol.2017.11.004. Epub 2017 Nov 10.
7
Effects of genetically proxied statins on diabetic nephropathy and retinopathy: a Mendelian randomization study.遗传邻近他汀类药物对糖尿病肾病和视网膜病变的影响:一项孟德尔随机研究。
Sci Rep. 2024 Jul 23;14(1):16885. doi: 10.1038/s41598-024-67800-5.
8
Genetic proxies for PCSK9 inhibition associate with lipoprotein(a): Effects on coronary artery disease and ischemic stroke.载脂蛋白(a)抑制的遗传替代物与脂蛋白(a)相关:对冠状动脉疾病和缺血性卒中的影响。
Atherosclerosis. 2022 Nov;361:41-46. doi: 10.1016/j.atherosclerosis.2022.09.007. Epub 2022 Sep 26.
9
Causal relationship between lipid-lowering drugs and ovarian cancer, cervical cancer: a drug target mendelian randomization study.降脂药物与卵巢癌、宫颈癌的因果关系:药物靶点孟德尔随机化研究。
BMC Cancer. 2024 May 31;24(1):667. doi: 10.1186/s12885-024-12434-z.
10
The relationship between lipoprotein(a) and risk of cardiovascular disease: a Mendelian randomization analysis.载脂蛋白(a)与心血管疾病风险的关系:一项孟德尔随机化分析。
Eur J Med Res. 2022 Oct 27;27(1):211. doi: 10.1186/s40001-022-00825-6.

引用本文的文献

1
Gain of function variants in PCSK9 gene in high risk patients after myocardial infarction with increased lipoprotein (a) values and treated with statins.心肌梗死后脂蛋白(a)值升高且接受他汀类药物治疗的高危患者中PCSK9基因的功能获得性变异。
Sci Rep. 2025 Jul 23;15(1):26753. doi: 10.1038/s41598-025-12432-6.

本文引用的文献

1
Correlations of PCSK9 and LDLR Gene Polymorphisms and Serum PCSK9 Levels With Atherosclerosis and Lipid Metabolism in Patients on Maintenance Hemodialysis.载脂蛋白 B 代谢关键基因 PCSK9 和 LDLR 基因多态性与维持性血液透析患者动脉粥样硬化及脂代谢的相关性
J Clin Pharmacol. 2023 Dec;63(12):1430-1437. doi: 10.1002/jcph.2332. Epub 2023 Oct 2.
2
Inclisiran, Low-Density Lipoprotein Cholesterol and Lipoprotein (a).英克西兰、低密度脂蛋白胆固醇和脂蛋白(a)
Pharmaceuticals (Basel). 2023 Apr 12;16(4):577. doi: 10.3390/ph16040577.
3
Common and Rare Variants Associated with Low-Density Lipoprotein Cholesterol Levels and the Risk of Diabetes Mellitus: A Mendelian Randomization Study.
常见和罕见变异与低密度脂蛋白胆固醇水平及糖尿病风险的关联:一项孟德尔随机化研究。
Int J Mol Sci. 2022 Sep 8;23(18):10418. doi: 10.3390/ijms231810418.
4
Existing and emerging strategies to lower Lipoprotein(a).现有的和新兴的降低脂蛋白(a)的策略。
Atherosclerosis. 2022 May;349:110-122. doi: 10.1016/j.atherosclerosis.2022.04.020.
5
Lipoprotein(a): A Genetically Determined, Causal, and Prevalent Risk Factor for Atherosclerotic Cardiovascular Disease: A Scientific Statement From the American Heart Association.脂蛋白(a):一种与遗传相关的、因果性的、普遍存在的动脉粥样硬化性心血管疾病风险因素:美国心脏协会的科学声明。
Arterioscler Thromb Vasc Biol. 2022 Jan;42(1):e48-e60. doi: 10.1161/ATV.0000000000000147. Epub 2021 Oct 14.
6
Modern Approaches to Lower Lipoprotein(a) Concentrations and Consequences for Cardiovascular Diseases.降低脂蛋白(a)浓度的现代方法及其对心血管疾病的影响
Biomedicines. 2021 Sep 20;9(9):1271. doi: 10.3390/biomedicines9091271.
7
PCSK9: A Multi-Faceted Protein That Is Involved in Cardiovascular Biology.前蛋白转化酶枯草溶菌素9:一种参与心血管生物学的多功能蛋白质。
Biomedicines. 2021 Jul 8;9(7):793. doi: 10.3390/biomedicines9070793.
8
PCSK9 Biology and Its Role in Atherothrombosis.PCSK9 生物学及其在动脉粥样血栓形成中的作用。
Int J Mol Sci. 2021 May 30;22(11):5880. doi: 10.3390/ijms22115880.
9
Genome-Wide Association Study and Identification of a Protective Missense Variant on Lipoprotein(a) Concentration: Protective Missense Variant on Lipoprotein(a) Concentration-Brief Report.全基因组关联研究及脂蛋白(a)浓度保护性错义变异的鉴定:脂蛋白(a)浓度保护性错义变异的简要报告。
Arterioscler Thromb Vasc Biol. 2021 May 5;41(5):1792-1800. doi: 10.1161/ATVBAHA.120.315300. Epub 2021 Mar 18.
10
Serum Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) is Independently Associated with Insulin Resistance, Triglycerides, Lipoprotein(a) Levels but not Low-Density Lipoprotein Cholesterol Levels in a General Population.在一般人群中,血清前蛋白转化酶枯草溶菌素 9(PCSK9)与胰岛素抵抗、甘油三酯、脂蛋白(a)水平独立相关,但与低密度脂蛋白胆固醇水平无关。
J Atheroscler Thromb. 2021 Apr 1;28(4):329-337. doi: 10.5551/jat.56390. Epub 2020 Jul 4.